Document Detail


Blood coagulation dynamics in haemostasis.
MedLine Citation:
PMID:  19151839     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Our studies involve computational simulations, a reconstructed plasma/platelet proteome, whole blood in vitro and blood exuding from microvascular wounds. All studies indicate that in normal haemostasis, the binding of tissue factor (TF) with plasma factor (F) VIIa (extrinsic FXase complex) results in the initiation phase of the procoagulant response. This phase is negatively regulated by tissue factor pathway inhibitor (TFPI) in combination with antithrombin (AT) and the protein C (PC) pathway. The synergy between these inhibitors provides a threshold-limited reaction in which a stimulus of sufficient magnitude must be provided for continuation of the reaction. With sufficient stimulus, the FXa produced activates some prothrombin. This initial thrombin activates the procofactors and platelets required for presentation of the intrinsic FXase (FVIIIa-FIXa) and prothrombinase (FVa-FXa) complexes which drive the subsequent propagation phase; continuous downregulation of which is provided by AT and the thrombin-thrombomodulin-PC complex. FXa generation during the propagation phase is largely (>90%) provided by the intrinsic FXase complex. TF is required for the initiation phase of the reaction but becomes non-essential once the propagation phase has been achieved. The propagation phase catalysts (FVIIIa-FIXa and FVa-FXa) continue to drive the reaction as blood is resupplied to the wound site by flow. Ultimately, the control of the reaction is governed by the pro- and anticoagulant dynamics and the supply of blood reactants to the site of a perforating injury. Our systems have been utilized to examine the qualities of hypothetical and novel antihaemorrhagic and anticoagulation agents and in epidemiologic studies of venous and arterial thrombosis and haemorrhagic pathology.
Authors:
K G Mann; T Orfeo; S Butenas; A Undas; K Brummel-Ziedins
Related Documents :
7312719 - A model of experimental atherosclerosis in pigs. part i. study on blood lipids and coag...
15617739 - Relationship between hemoconcentration and blood coagulation responses to acute mental ...
19290079 - A study of the quantity of some stable and labile coagulation factors in fresh-frozen p...
18761519 - Validation of thromboelastometry in horses.
16626779 - The influence of physical-chemical and biological factors on the removal of faecal coli...
20955299 - Thromboelastography in healthy horses and horses with inflammatory gastrointestinal dis...
19555419 - Blood salvage use in gynecologic oncology.
21454159 - The protective role of glutathione in silver induced toxicity in blood components.
7968469 - Microvascular response in the rabbit ear to total body cooling: a model for study of hu...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Hämostaseologie     Volume:  29     ISSN:  0720-9355     ISO Abbreviation:  Hamostaseologie     Publication Date:  2009 Jan 
Date Detail:
Created Date:  2009-01-19     Completed Date:  2009-03-24     Revised Date:  2011-08-25    
Medline Journal Info:
Nlm Unique ID:  8204531     Medline TA:  Hamostaseologie     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  7-16     Citation Subset:  IM    
Affiliation:
University of Vermont, Department of Biochemistry, Burlington, VT, USA. Kenneth.Mann@uvm.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Coagulation / physiology*
Blood Coagulation Factors / metabolism
Blood Proteins / metabolism
Fibrinogen / metabolism
Hemostasis / physiology*
Humans
Kinetics
Models, Biological
Proteome
Thrombin / metabolism
Grant Support
ID/Acronym/Agency:
P01 HL046703-16A1/HL/NHLBI NIH HHS; P01 HL046703-17/HL/NHLBI NIH HHS; P01 HL46703/HL/NHLBI NIH HHS; R01 HL034575-20/HL/NHLBI NIH HHS; R01 HL034575-21/HL/NHLBI NIH HHS; R01 HL34575/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Blood Coagulation Factors; 0/Blood Proteins; 0/Proteome; 9001-32-5/Fibrinogen; EC 3.4.21.5/Thrombin
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Multilayer structure for a spectral imaging sensor.
Next Document:  Mouse models to study von Willebrand factor structure-function relationships in vivo.